Shares of H&H International Holdings soared 7.23% during Thursday's intraday trading session following the release of its impressive first-quarter financial results.

The company reported a total revenue of 4.26 billion yuan for Q1 2026, representing a significant 34% increase compared to the same period last year. The growth was particularly strong across its core segments, with revenue from adult nutrition and care products jumping 26% to 1.93 billion yuan, while infant nutrition and care products revenue surged 61% to 1.83 billion yuan.

The company attributed the robust performance to the phasing effect of the Chinese New Year holidays and a temporary rise in demand for its Biostime infant milk formulas amid new industry developments. The pet nutrition segment was the only division to see a slight decline, with revenue slipping 1.5% to 493.4 million yuan.